November 10, 2016 / 9:12 PM / in 10 months

BRIEF-Oncogenex Pharmaceuticals reports Q3 loss per share $0.12

Nov 10 (Reuters) - Oncogenex Pharmaceuticals Inc -

* Oncogenex Pharmaceuticals Inc reports financial results for third quarter 2016

* Qtrly loss per share $0.12

* Qtrly revenue $3.8 million versus $3.1 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below